Proscia Gains Recognition as AI Pathology Adoption Expands
PHILADELPHIA, PA — Proscia was recognized in the 2026 MedTech Breakthrough Awards as pharmaceutical companies increasingly adopt artificial intelligence and digital pathology tools to accelerate biomarker research and precision medicine …
Proscia Gains Recognition as AI Pathology Adoption Expands Read More